The Prevalence of Multidrug-Resistant Enterobacteriaceae among Neonates in Kuwait
暂无分享,去创建一个
[1] B. Posteraro,et al. Molecular Mechanisms, Epidemiology, and Clinical Importance of β-Lactam Resistance in Enterobacteriaceae , 2020, International journal of molecular sciences.
[2] Jian Sun,et al. Harnessing efficient multiplex PCR methods to detect the expanding Tet(X) family of tigecycline resistance genes , 2019, Virulence.
[3] Rui Wang,et al. Resistance to Ceftazidime-Avibactam and Underlying Mechanisms. , 2019, Journal of global antimicrobial resistance.
[4] U. Ozumba,et al. Molecular detection and antibiotic resistance pattern of extended-spectrum beta-lactamase producing Escherichia coli in a Tertiary Hospital in Enugu, Nigeria , 2019, Annals of Clinical Microbiology and Antimicrobials.
[5] M. Aguilar,et al. Folic Acid Antagonists: Antimicrobial and Immunomodulating Mechanisms and Applications , 2019, International journal of molecular sciences.
[6] J. Bielicki,et al. Future Challenges in Pediatric and Neonatal Sepsis: Emerging Pathogens and Antimicrobial Resistance , 2019, Journal of Pediatric Intensive Care.
[7] S. Sharara,et al. Epidemiology of common resistant bacterial pathogens in the countries of the Arab League. , 2018, The Lancet. Infectious diseases.
[8] Wei Wang,et al. Antibiotic resistance: a rundown of a global crisis , 2018, Infection and drug resistance.
[9] S. Głuszek,et al. The genetic background of antibiotic resistance among clinical uropathogenic Escherichia coli strains , 2018, Molecular Biology Reports.
[10] V. Rotimi,et al. The Prevalence of Extended-Spectrum β-lactamase (ESBL) - And Carbapenem–Resistant Enterobacteriaceae (CRE) Isolates in Positive Blood Cultures of Patients in A Teaching Hospital in Kuwait Over A 2-year Period , 2017 .
[11] P. Hawkey,et al. Global epidemiology of CTX-M &bgr;-lactamases: temporal and geographical shifts in genotype , 2017, The Journal of antimicrobial chemotherapy.
[12] M. Sharland,et al. Antimicrobial-resistant Gram-negative infections in neonates: burden of disease and challenges in treatment , 2017, Current opinion in infectious diseases.
[13] Y. Arakawa,et al. Aminoglycoside Resistance: The Emergence of Acquired 16S Ribosomal RNA Methyltransferases. , 2016, Infectious disease clinics of North America.
[14] S. Garneau‐Tsodikova,et al. Mechanisms of Resistance to Aminoglycoside Antibiotics: Overview and Perspectives. , 2016, MedChemComm.
[15] R. Lundin,et al. Antibiotic Resistance Prevalence in Routine Bloodstream Isolates from Children’s Hospitals Varies Substantially from Adult Surveillance Data in Europe , 2015, The Pediatric infectious disease journal.
[16] S. Partridge. Resistance mechanisms in Enterobacteriaceae. , 2015, Pathology.
[17] O. Ojo-bola. Carriage of Antibiotic Resistant Commensal E. coli in Infants below 5 Months in Ado-Ekiti , 2015 .
[18] F. Hu,et al. Mechanisms of Tigecycline Resistance among Klebsiella pneumoniae Clinical Isolates , 2014, Antimicrobial Agents and Chemotherapy.
[19] J. Fisher,et al. Acquired Class D β-Lactamases , 2014, Antibiotics.
[20] J. Ayala,et al. β-lactamases produced by amoxicillin-clavulanate-resistant enterobacteria isolated in Buenos Aires, Argentina: a new blaTEM gene. , 2014, Revista Argentina de microbiologia.
[21] D. Stenger,et al. Multidrug-resistant tet(X)-containing hospital isolates in Sierra Leone. , 2013, International journal of antimicrobial agents.
[22] Xuejun Ma,et al. A high throughput multiplex PCR assay for simultaneous detection of seven aminoglycoside-resistance genes in Enterobacteriaceae , 2013, BMC Microbiology.
[23] N. V. Trung,et al. High prevalence of antibiotic resistance in commensal Escherichia coli among children in rural Vietnam , 2012, BMC Infectious Diseases.
[24] M. Falagas,et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[25] Rafael Cantón,et al. EUCAST guidelines for detection of resistance mechanisms and specific resistances of clinical and/or epidemiological importance , 2012 .
[26] P. Nordmann,et al. Multiplex PCR for detection of acquired carbapenemase genes. , 2011, Diagnostic microbiology and infectious disease.
[27] Anton Y Peleg,et al. Hospital-acquired infections due to gram-negative bacteria. , 2010, The New England journal of medicine.
[28] L. Martínez-Martínez,et al. Detection of Plasmid-Mediated Quinolone Resistance Genes in Clinical Isolates of Enterobacter spp. in Spain , 2009, Journal of Clinical Microbiology.
[29] G. Kahlmeter,et al. Standard and real-time multiplex PCR methods for detection of trimethoprim resistance dfr genes in large collections of bacteria. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[30] D. Andersson. The ways in which bacteria resist antibiotics , 2005 .
[31] J. Blondeau. Fluoroquinolones: mechanism of action, classification, and development of resistance. , 2004, Survey of ophthalmology.
[32] M. Ferraro. Performance standards for antimicrobial susceptibility testing , 2001 .
[33] J Davies,et al. Bacterial resistance to aminoglycoside antibiotics. , 1997, The Journal of infectious diseases.